Mayukh Sukhatme, President & CIO at Roivant Sciences Ltd. (ROIV), sold 4,529,103 shares at $21.74 ($98.4M) on 2025-12-29, disclosed to the SEC on 2025-12-31.
Open-market sale of $98.4M ROIV by President & CIO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.74 | 311,873 | $6.8M | 6.9% |
| 2 | $21.74 | 311,873 | $6.8M | 6.9% |
| 3 | $21.74 | 436,485 | $9.5M | 9.6% |
| 4 | $21.71 | 1,018,995 | $22.1M | 22.5% |
| 5 | $21.71 | 1,018,995 | $22.1M | 22.5% |
| 6 | $21.71 | 1,430,882 |
| $31.1M |
| 31.6% |
| Total | $21.72 avg | 4,529,103 | $98.4M | 100% |
| Filing → |
| ROIV | SELL | 2026-06-29 | $34.1M | — | Filing → |
| ROIV | SELL | 2026-02-11 | $9.0M | — | Filing → |
| ROIV | SELL | 2025-12-19 | $1.2M | — | Filing → |